- Home
- MDV vs ALEC Comparison
MDV vs ALEC Comparison
Compare MDV & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDV
- ALEC
- Stock Information
- Founded
- MDV 2015
- ALEC 2013
- Country
- MDV United States
- ALEC United States
- Employees
- MDV N/A
- ALEC N/A
- Industry
- MDV Transportation Services
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDV Consumer Discretionary
- ALEC Health Care
- Exchange
- MDV Nasdaq
- ALEC Nasdaq
- Market Cap
- MDV 147.6M
- ALEC 124.0M
- IPO Year
- MDV 2022
- ALEC 2019
- Fundamental
- Price
- MDV $14.52
- ALEC $1.26
- Analyst Decision
- MDV
- ALEC Hold
- Analyst Count
- MDV 0
- ALEC 9
- Target Price
- MDV N/A
- ALEC $3.40
- AVG Volume (30 Days)
- MDV 32.1K
- ALEC 5.2M
- Earning Date
- MDV 11-14-2025
- ALEC 11-06-2025
- Dividend Yield
- MDV 8.06%
- ALEC N/A
- EPS Growth
- MDV N/A
- ALEC N/A
- EPS
- MDV N/A
- ALEC N/A
- Revenue
- MDV $47,273,000.00
- ALEC $81,130,000.00
- Revenue This Year
- MDV $1.88
- ALEC N/A
- Revenue Next Year
- MDV $2.41
- ALEC $290.64
- P/E Ratio
- MDV N/A
- ALEC N/A
- Revenue Growth
- MDV N/A
- ALEC 46.77
- 52 Week Low
- MDV $13.62
- ALEC $0.87
- 52 Week High
- MDV $17.71
- ALEC $6.14
- Technical
- Relative Strength Index (RSI)
- MDV 47.91
- ALEC 24.47
- Support Level
- MDV $14.30
- ALEC $1.45
- Resistance Level
- MDV $14.75
- ALEC $1.68
- Average True Range (ATR)
- MDV 0.27
- ALEC 0.18
- MACD
- MDV 0.00
- ALEC -0.10
- Stochastic Oscillator
- MDV 38.12
- ALEC 0.24
About MDV Modiv Industrial Inc. Class C
Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.